Endpoint definition
↥Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
endocrine neoplasm: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Benign neoplasm of other and unspecified endocrine glands based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 1981 | 1188 | 793 |
Unadjusted prevalence (%) | 0.76 | 0.81 | 0.70 |
Mean age at first event (years) | 55.29 | 53.57 | 57.88 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.05 | 3.32 [2.09, 5.27] | 3.7e-7 | 131 |
15 years | 0.02 | 3.57 [2.20, 5.81] | 2.7e-7 | 119 |
5 years | 0.01 | 5.24 [3.30, 8.32] | 2.4e-12 | 55 |
1 year | 0.00 | 9.11 [5.08, 16.33] | 1.2e-13 | 18 |
Index endpoint: CD2_BENIGN_ENDOCRINE_OTH – Benign neoplasm of other and unspecified endocrine glands
GWS hits: 0
before Benign neoplasm of other and unspecified endocrine glands
after Benign neoplasm of other and unspecified endocrine glands
Loading survival analyses plot
Loading survival analyses table